Kenji Nakahama
Higashi-osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Geriatric Assessment with Geriatric-8, Body Weight Loss, and Bioelectrical Impedance Analysis in Older Patients with Lung Cancer: A Single-Center Retrospective Study.
Journal: JMA journal
Published: August 23, 2025
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer.
Journal: Scientific reports
Published: March 26, 2024
Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study.
Journal: Clinical lung cancer
Published: October 01, 2023
Tract creation with a 25-gauge needle for convex endobronchial ultrasound-guided core biopsy in intrapulmonary lesions adjacent to bronchi: three case reports.
Journal: Translational lung cancer research
Published: August 27, 2023
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression.
Journal: Anticancer research
Published: July 21, 2023
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
Journal: JTO clinical and research reports
Published: June 02, 2023
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: May 31, 2023
Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world Data.
Journal: Anticancer research
Published: February 20, 2023
SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3.
Journal: Translational lung cancer research
Published: July 01, 2022
Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.
Journal: Thoracic cancer
Published: May 09, 2022
Last Updated: 09/26/2026